Tatsuta M, Iishi H, Okuda S
Gut. 1987 May;28(5):561-5. doi: 10.1136/gut.28.5.561.
The extent of acid secreting areas and the distribution of intestinal metaplasia in patients with erosive gastritis, and the healing effects of pirenzepine were examined. Studies were done with the endoscopic Congo red-methylene blue test developed in our hospital. Compared with control patients with no gastroduodenal disease, erosive gastritis was associated significantly more frequently with large acid secreting areas, but little or no intestinal metaplasia was detected in the stomach. A double blind trial was carried out, using 100 mg pirenzepine tablets or placebo for three months in 43 patients with erosive gastritis. Endoscopically, complete healing was significantly more frequent in the pirenzepine treated groups three months after the start of the treatment, as compared with the placebo treated group (p less than 0.05).
研究了糜烂性胃炎患者胃酸分泌区域的范围和肠化生的分布情况,以及哌仑西平的治疗效果。采用我院研发的内镜下刚果红-亚甲蓝试验进行研究。与无胃十二指肠疾病的对照患者相比,糜烂性胃炎患者胃酸分泌区域大的情况更为常见,但胃内肠化生很少或未检测到。对43例糜烂性胃炎患者进行了双盲试验,给予100mg哌仑西平片或安慰剂,为期3个月。在内镜检查中,治疗开始3个月后,哌仑西平治疗组的完全愈合率明显高于安慰剂治疗组(p<0.05)。